RecruitingNot ApplicableNCT06401863

Shared Decision for Drug Interactions in Oral Anticoagulation

Implementation of DDInteract A Shared-decision Making Tool for Anticoagulant Drug-Drug INTERACTions (DDinteract)


Sponsor

University of Utah

Enrollment

3,691 participants

Start Date

Oct 1, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this project is to implement and evaluate a shared-decision making (SDM) tool called DDInteract that was developed to support decision making for drug-drugs interactions while on oral anticoagulants. DDInteract will be implemented in clinics at the University of Utah, University of Colorado and University of Vanderbilt. DDInteract will be launched from within the electronic health record (EHR) retrieving patient-specific risk factors, will calculate the risk of harm, and will allow providers and patients to dynamically explore "what if" scenarios to optimize treatment and minimize risk. DDInteract will enable shared-decision making using individually-tailored information on the potential benefits and harms of drug interactions in anticoagulated patients.


Eligibility

Min Age: 21 Years

Inclusion Criteria2

  • Be at least 21 years of age or older
  • Receive more than one prescription of an oral anticoagulant (i.e. warfarin, apixaban, edoxaban, dabigatran, rivaroxaban)

Exclusion Criteria1

  • Individuals not able to speak English or Spanish

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERShared Decision Making Tool

EHR-integrated SDM for Patients on Oral Anticoagulants and other medications that might increase the risk of hemorrhage


Locations(3)

University of Colorado. School of Medicine

Denver, Colorado, United States

Vanderbilt University

Nashville, Tennessee, United States

University of Utah

Salt Lake City, Utah, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06401863


Related Trials